Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-034919

Chief Medical Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kropotova Alexandra Chief Medical Officer 2022-06-06 Grant or award +300,000 300,000 D
Loading xslF345X03/doc4.xml…